Home
InSilico Medicine, Inc.

InSilico Medicine, Inc. Market Share Analysis for August 2026

Generative AI and Automation for Longevity and Sustainability

Science and Education > Biology

Domaininsilico.com

Year Founded2014

Employees51 - 200

Annual Revenue$25M - $50M

InSilico Medicine, Inc.

InSilico Medicine, Inc. (including company regionals)

insilico.com

See more website traffic and engagement information

InSilico Medicine, Inc. Revenue up to August 2026 is 25M - 50M

revenue generated by InSilico Medicine, Inc. top domains

InSilico Medicine, Inc. top domains revenue over 3 years

Revenue for InSilico Medicine, Inc. top domains

insilico.com25M - 50M

See more with Sales Intelligence

Total visits to InSilico Medicine, Inc.'s top domains

Understand InSilico Medicine, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

insilico.com49K

See more with Sales Intelligence

Avg. visit duration in InSilico Medicine, Inc.'s top domains

Analyze InSilico Medicine, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

insilico.com00:01:21

See more with Sales Intelligence

Avg. pageviews on InSilico Medicine, Inc.'s top domains

See how InSilico Medicine, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

insilico.com1.66

See more with Sales Intelligence

InSilico Medicine, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

recursion.comCompany NameRecursionEmployees501 - 1000HQUnited States, Utah, Salt Lake CityAnnual revenue$10M - $15MTotal visits87.7KHealth > Health - Other

Top technologies used by InSilico Medicine, Inc.

These are the website technologies, by industry, used by InSilico Medicine, Inc. top domains

Mobile (3)

Meta Viewport

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Email Services (2)

G Suite

More Technologies

13

See all

News & Signals from InSilico Medicine, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInsilico Medicine, Inc. is developing drug rentosertib on Sep 9th '26.Initially, Insilico Medicine developed the experimental drug rentosertib to treat patients with chronic lung diseases and potentially extend lifespan.

NewsInsilico Medicine, Inc. had earnings of $51M on Apr 1st '26.Recently, Insilico reported total revenue of approximately $106 million in the first half of 2026, a 287% year-over-year increase, and achieved its first profitable half-year since listing, with an adjusted net profit exceeding $51 million.